RT @Janetbirdope: High markers at baseline of IL23 pathway better predict ACR20 response to #deucracitinib in #PsA #psor
Tweet Content
High markers at baseline of IL23 pathway better predict ACR20 response to #deucracitinib in #PsA #psoriatic arthritis. Analysis of RCT @eular_org @RheumNow #POS0005 Good proof of concept of TYK2 efficacy https://t.co/yyH5niUEEU
Show on Archive Page
On
Display in Search Results
On
PDQ
Off